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Background: Hypoalbuminemia is a risk factor for cardiovascular events and mortality in 
dialysis patients, but the underlying mechanism remains unclear. Meanwhile, increased pulse 
wave velocity (PWV), the marker of arterial stiffness, has been proved to be an independent 
predictor of cardiovascular disease. The relationship between serum albumin and PWV in 
continuous ambulatory peritoneal dialysis patients (CAPD) was studied.
Methods: Sixty-two CAPD patients were studied. The average age was 63 ± 12 years and 
dialysis duration was 23 ± 22 months. Serum albumin, C-reactive protein (CRP), and carotid-
femoral PWV were measured.
Results: Among these patients, 43.5% were men. The mean serum albumin concentration 
was 37 ± 4 g/L and PWV was 11.9 ± 2.3 m/s. PWV positively correlated with age (r = 0.35, 
P  0.01), diabetes (yes = 1, no = 0; r = 0.292, P  0.05), systolic blood pressure (SBP; 
r = 0.493, P  0.001) and CRP (r = 0.295, P  0.05), but negatively correlated with serum 
albumin (r = −0.357, P  0.01). In multiple regression analysis, SBP (β = 0.615, P  0.001), 
age (β = 0.414, P  0.01), albumin (β = −0.315, P  0.05) and total cholesterol (β = 0.275, 
P  0.05) were independent determinants of PWV. In a non-inﬂ  amed subgroup (CRP  3 mg/L, 
n = 30), albumin still negatively correlated with PWV (r = −0.66, P  0.001).
Conclusion: Serum albumin inversely correlated with increased PWV in CAPD patients, 
suggesting that increased arterial stiffness might be the link between hypoalbuminemia and 
increased cardiovascular mortality in dialysis patients.
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Introduction
In dialysis patients, a number of studies have suggested that hypoalbuminemia is an 
independent predictor of increased cardiovascular events and mortality (Foley et al 
1996; Wong et al 2002; Cooper et al 2004; Kalantar-Zadeh et al 2005). There are also 
reports that hypoalbuminemia is closely associated with left ventricular hypertrophy 
(LVH) in dialysis patients (Foley et al 1995; Enia et al 2001). However, the underlying 
mechanism by which hypoalbuminemia leads to LVH and increased cardiovascular 
events remains unclear. In recent years, many studies have also proved that increased 
aortic stiffness is a risk factor for cardiovascular events and mortality (Benetos et al 
1998; Asmar et al 2001; Laurent et al 2001; Hansen et al 2006). It is thus reasonable 
to hypothesize that there might be a close association between hypoalbuminemia and 
markers of aortic stiffness.
In our previous study, we found a negative correlation between serum albu-
min and pulse pressure (PP), the surrogate of arterial stiffness (Vlachopoulos and 
O’Rourke 2000; Dart and Kingwell 2001; Van Bortel et al 2001) in a group of Vascular Health and Risk Management 2008:4(4) 872
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continuous ambulatory peritoneal dialysis (CAPD) patients 
(unpublished data). However, PP is not the true marker 
of arterial stiffness. Therefore, in the present study, we 
employed pulse wave velocity (PWV), the direct measure 
of arterial stiffness (O’Rourke et al 2002), and explored the 
relationship between serum albumin and PWV in CAPD 
patients. To clarify the confounding effect of inﬂ  ammation, 
we additionally analyzed the relationship between serum 
albumin and PWV in a subgroup of patients without evi-
dence of inﬂ  ammation.
Patients and methods
Study population
In this cross-sectional study, we included all stable patients 
treated with CAPD in the Peritoneal Dialysis Center of Peking 
University Third Hospital in May, 2006. The exclusion 
criteria were: 1) dialysis duration less than 3 months; 2) 
presence of congestive heart failure; and 3) hypotension 
(deﬁ  ned as systolic blood pressure/diastolic blood pres-
sure 90/60 mmHg). Based on these criteria, 62 patients 
were considered suitable for this study. The study protocol 
was approved by the ethic committee of our hospital and 
informed consent was obtained from every patient.
Measurement of carotid-femoral 
pulse wave velocity
Aortic PWV was determined using an automatic device, the 
Complior (Colson, Garges les Gonesses, France) (Asmar 
et al 1995), which allowed online pulse wave recording and 
automatic calculation of PWV. Common carotid artery and 
femoral artery pressure wave forms were recorded noninva-
sively using a TY-306 Fukuda pressure sensitive transducer 
(Fukuda, Tokyo, Japan). Measurement was repeated over 
10 different cardiac cycles, and the mean value was used 
for the ﬁ  nal analysis. The distance traveled by the pulse 
wave was measured over the body surface as the distance 
between the two recording sites (D), while pulse transit time 
(t) was automatically determined by the Complior. Pulse 
wave velocity was automatically calculated as PWV = D/t. 
Details, as well as validation of this automatic method and 
its reproducibility, have been reported previously (Asmar 
et al 1995). All the PWV measurements were performed by 
one doctor (L-J Tang) and the intra-observer CV was about 
1.74%–7.95%.
Measurement of blood pressure
To ensure the accuracy of measurements, a dedicated renal 
nurse was in charge of all blood pressure (BP) measurements, 
and the mercury sphygmomanometer used was calibrated 
regularly. All measurements were performed in a quiet room. 
Brachial BP was measured twice in a sitting position after 
patients had rested more than ten minutes. Systolic blood 
pressure (SBP) and diastolic blood pressure (DBP) were 
averaged from values of the two measurements.
Biochemical measurements
Serum albumin was determined by the bromcresol green 
method. High sensitive C-reactive protein (CRP) was mea-
sured as inﬂ  ammatory index and a CRP value 3 mg/L was 
considered as the presence of inﬂ  ammation. This method 
could not detect CRP levels 0.01 mg/L. Other biochemi-
cal indices, such as serum calcium, phosphate, triglycerides, 
total cholesterol lipoprotein, low-density lipoprotein, and 
high-density lipoprotein were determined with standard 
methods.
Measurements of ﬂ  uid status
Extracellular water (ECW) was measured by multiple-frequency 
bioelectrical impedance analysis (Xitron Technologies, San 
Diego, CA). The procedure to perform this measurement was 
described in detail elsewhere (Cheng et al 2005). Brieﬂ  y, 
after patients taking supine position for at least 10 minutes, 
the standard tetrapolar electrodes were placed on the dorsum 
of wrist and anterior aspect of the ankle on the left side of 
the body. Three consecutive measurements were performed 
over a 2-min period, and ECW was calculated as the mean 
values of the three measurements.
Statistical analysis
Continuous variables were expressed as mean ± SD while 
categorical variables were expressed as percentage or ratio. 
Pearson’s and Spearman’s correlations were performed to 
explore the relationships between serum albumin and other 
variables as appropriate. Multiple regression analysis was 
performed to determine the relationship between serum 
albumin and PWV to control the inﬂ  uence of other variables. 
All tests were two-sided. A value of P  0.05 was taken as 
statistically signiﬁ  cant. All analysis was completed with 
SPSS software, version 11.0 (SPSS, Chicago, IL).
Results
Demographic characteristics of the study 
population
The demographic characteristics of the patients included in 
this study were shown in Table 1. There were 27 male and 
35 female patients, with an average age of 63 ± 12 years Vascular Health and Risk Management 2008:4(4) 873
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old (range 23 to 85). The mean dialysis duration in these 
patients was 23 ± 22 months. The mean serum albumin was 
37 ± 4 g/L. The mean PWV was 11.96 ± 2.27 m/s.
Univariate correlation multiple 
regression analysis
Univariate correlation analysis between PWV and other 
possible affecting factors were shown in Table 2. PWV 
was positively correlated with age (r = 0.35, P  0.01), 
diabetic status (yes = 1, no = 0; r = 0.292, P  0.05), SBP 
(r = 0.493, P  0.001) and CRP (r = 0.295, P  0.05), but 
negatively correlated with serum albumin (r = −0.357, 
P  0.01; Figure 1A). The correlations between PWV 
and ECW and phosphate were just borderline (r = 0.241, 
P  = 0.077 and r = −0.244, P = 0.056, respectively). No 
correlation was found between PWV and sex (female = 1, 
male = 0), height, dialysis duration, DBP, antihypertensive 
medication (yes = 1, no = 0), serum calcium, and total 
cholesterol.
Multiple stepwise regression analysis to determine the 
relationship between PWV and other possible affecting 
factors was shown in Table 3. In this model, PWV was 
treated as dependent variable while a series of factors 
were treated as independent variables, such as age, sex 
(female = 1, male = 0), dialysis duration, diabetic status 
(yes = 1, no = 0), SBP, DBP, antihypertensive medication 
(yes = 1, no = 0), ECW, serum calcium, serum phosphate, 
total cholesterol, CRP, and serum albumin. The result of 
multiple stepwise regression analysis showed that SBP 
(0.615, P  0.001), age (0.414, P  0.01), serum albumin 
(−0.315, P  0.05) and total cholesterol (0.275, P  0.05) 
were independent determinants of PWV after adjusting 
other possible confounding factors. The adjusted R Square 
for this model was 0.627.
Univariate correlation analysis in patients 
without inﬂ  ammation
To exclude the confounding effect of inﬂ  ammation on correla-
tion between serum albumin and PWV, univariate correlation 
analysis was further performed in patients without evidence 
of inﬂ  ammation. Among the 62 patients, 30 patients with 
CRP values less than 3 mg/L were considered as noninﬂ  amed 
patients and selected into the subgroup analysis. The correla-
tion analysis showed that serum albumin was still negatively 
correlated with PWV (r = −0.66, P  0.001; Figure 1B). 
Because there were also signiﬁ  cant correlations between serum 
albumin and age and diabetic status (data not shown), partial 
correlation analysis was performed to control the possible 
effect of age and diabetic status on PWV. The partial correla-
tion showed that there was still negative correlation between 
serum albumin and PWV (r = −0.412, P  0.05). Given the 
relatively small sample in this non-inﬂ  amed subgroup, multiple 
stepwise regression analysis was not performed.
Table 1 Demographic characteristics of the study population
Number of patients  62
Sex, male/female  27/35
Age, year  63 ± 12
Height, cm  157 ± 14
Weight, kg  61 ± 17
Dialysis duration, month  23 ± 22
Antihypertensive medication, Yes/No  52/10
Primary diagnosis 
 Chronic  glomerulonephritis,  30.6%
 Hypertension  24.2%
 Diabetes  17.7%
 Tubulointerstitial  nephritis  11.3%
 Unknown  16.1%
Systolic blood pressure, mmHg  149 ± 23
Diastolic blood pressure, mmHg  84 ± 13
Extracellular water, L  14.7 ± 3.2
Serum calcium, mmol/L  2.25 ± 0.23
Serum phosphate, mmol/L  1.56 ± 0.43
Total cholesterol, mmol/L  4.96 ± 1.06
Serum albumin, g/L  37 ± 4
Serum CRP, mg/L  6.6 ± 6.8
rKt/V 0.48  ± 0.55
pKt/V 1.27  ± 0.44
tKt/V 1.75  ± 0.55
PWV, m/s  11.96 ± 2.27
Abbreviations: CRP, C-reactive protein; rKt/V, renal Kt/V; pKt/V, peritoneal Kt/V; 
tKt/V, total Kt/V (rKt/V+pKt/V); PWV, pulse wave velocity.
Table 2 Correlation analysis between PWV and other possible 
affecting factors
Variables  Correlation   P value
 coefﬁ  cient
Sex: female = 1, male = 0  −0.043 NS
Age 0.35  0.005
Height  −0.036 NS
Diabetes Mellitus: yes = 1,  0.292  0.021
no = 0
Dialysis duration  0.132  NS
SBP 0.493  0.001
DBP  −0.006 NS
AHM: yes = 1, no = 0  0.133  NS
Extracellular water  0.241  0.077
Calcium  −0.103 NS
Phosphate  −0.244 0.056
Total cholesterol  0.148  NS
CRP 0.295  0.036
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; AHM, 
antihypertensive medication; CRP, C-reactive protein.Vascular Health and Risk Management 2008:4(4) 874
Cheng et al
Discussion
In these CAPD patients studied, there was a close association 
between serum albumin and PWV: 1) serum albumin was 
negatively correlated with PWV; 2) serum albumin was one 
of the independent determinants of PWV; and 3) the inverse 
association between serum albumin and PWV could still 
be observed in a subgroup of patients without evidence of 
inﬂ  ammation.
The aortic PWV reflects central arterial stiffness 
(O'Rourke et al 2002). Previous studies have shown that 
PWV is a predictor of cardiovascular outcome in the gen-
eral population (Hansen et al 2006) and in patients with 
hypertension (Asmar et al 2001; Laurent et al 2001; Bout-
ouyrie et al 2002), diabetes (Cruickshank et al 2002), and 
hemodialysis (Blacher et al 1999) patients. On the other 
hand, the attenuation of PWV is related to improved clinical 
outcome in dialysis patients (Guerin et al 2001). Therefore, 
PWV was employed as the marker of aortic stiffness in the 
present study.
In univariate correlation analysis, we found that PWV 
was negatively associated with serum albumin, but posi-
tively correlated with age, diabetic status, SBP, and CRP 
(Table 2). While PWV failed to show any correlation with 
other possible affecting factors, such as sex, height, dialysis 
duration, DBP, antihypertensive medication, ECW, serum 
calcium, phosphate, total cholesterol and CRP. Given the 
limitation of univariate analysis in differentiating confound-
ing factors, multiple stepwise regression analysis was further 
performed by including all these possible factors as indepen-
dent variables. The regression analysis identiﬁ  ed that SBP, 
age, serum albumin and total cholesterol were independent 
determinants of PWV in these dialysis patients. These four 
factors could explain about 62.7% of variation in PWV in 
principle (adjusted R Square = 0.627, Table 3). It should be 
noted that the effect of serum albumin on PWV was inde-
pendent from the mediating effect of inﬂ  ammation, which 
was not only demonstrated in multiple regression analysis 
but also in the subsequent subgroup analysis. To further 
clarify the confounding effect of inﬂ  ammation on the rela-
tionship between serum albumin and PWV, a subgroup of 
patients without inﬂ  ammation (CRP  3 mg/L, n = 30) were 
taken out and studied separately. The univariate correlation 
analysis showed that serum albumin was still negatively 
correlated with PWV (Figure 1B). This inverse association 
between serum albumin and PWV could still be observed 
even controlling age and diabetic status in partial correla-
tion analysis. In line with our observation, a previous study 
showed that a lower albumin level was associated with a 
multiply adjusted risk of 2.1 for 4-year mortality compared 
with those with higher albumin in persons who did not have 
evidence of inﬂ  ammation (indicated by a high interleukin-6 
level) (Reuben et al 2000).
The close association between lower serum albumin and 
increased PWV, the marker of increased aortic stiffness, 
might be explained by the following mechanisms. First, 
there were evidences that hypoalbuminemia was associated 
with increased oxidative stress in dialysis patients. Using 
plasma protein thiol oxidation and protein carbonyl forma-
tion as indictors of oxidative stress, Danielski and colleagues 
(2003) found that oxidative stress was signiﬁ  cantly elevated 
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Figure 1 Pearson’s correlation between serum albumin and carotid-femoral pulse wave velocity: (A) In the whole study population (n = 62); (B) In patients without inﬂ  ammation 
(C-reactive protein  3 mg/L).
Abbreviation: C-F PWV, carotid-femoral pulse wave velocity.Vascular Health and Risk Management 2008:4(4) 875
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in hypoalbuminemia group as compared with normoalbumin-
emia group. Increased oxidative stress, in turn, could acceler-
ate atherosclerosis process. On the other hand, intravenously 
administered albumin was associated with increased plasma 
thiol levels, which improved antioxidant function (Quinlan 
et al 2004). Second, hypoalbuminemia was also found to 
have a close association with endothelial dysfunction in 
nephrotic syndrome (Joles et al 1999; Dogra et al 2002) 
and dialysis patients (Borawski et al 2001). Von Willebrand 
factor, an established index of endothelial dysfunction in 
patients with atherosclerotic cardiovascular disease (Lip and 
Blann 1995; Blann 2004), was found to correlate inversely 
with serum albumin in hemodialysis patients (Borawski 
et al 2001). Third, it was well known that hypoalbuminemia 
was often accompanied with dyslipidemia in patients with 
nephrotic syndrome (Cameron 1987; Joven et al 1996) and 
dialysis patients (Shoji et al 1991; Scolnik and Balfe 1993). 
Dyslimiemia played an important role in the pathogenesis 
of atherosclerosis and was one of the long identiﬁ  ed risk 
factor for cardiovascular disease. There was also a report 
that in CAPD patients, albumin infusion would signiﬁ  cantly 
decrease the levels of lipoprotein (a), an independent risk 
factor for atherosclerotic cardiovascular disease (Yang et al 
1997). The aforementioned atherogenic mechanisms related 
to hypoalbuminemia might explain why hypoalbuminemia 
was identiﬁ  ed as an independent risk factor for elevated PWV 
in CAPD patients.
There were some limitations in the present study. First, the 
cross-sectional design in this study limited our ability to infer a 
causal relationship between serum albumin and PWV. Indeed, 
totally opposite explanation might also reasonable. As a result, 
the relationship between serum albumin and pulse wave veloc-
ity should be veriﬁ  ed in future interventional studies. Second, 
although a number of potential confounding factors such as 
sex, age, diabetes, lipid proﬁ  le, antihypertensive medication, 
calcium and phosphate levels were controlled in multiple 
regression analysis, the existence of other unrecognized 
confounding variables was always possible. Third, this study 
was conducted in relatively older dialysis patients (mean age 
was 63 years), therefore, the extrapolation of the result in this 
study to other population, especially younger patients and 
nondialysis patients may not be appropriate. Indeed, there 
was a report that the association between hypoalbuminemia 
and markers of arterial stiffness could not be observed in a 
nondialysis population (Djousse et al 2003).
In conclusion, this study performed in dialysis patients 
showed that serum albumin was independently associated 
with PWV. The inverse association between serum albumin 
and PWV suggested that increased arterial stiffness might be 
the link between hypoalbuminemia and increased cardiovas-
cular events and mortality in dialysis patients.
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